CNY 7.96
(1.92%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 215.04 Million | -123.43 Million | 283.95 Million | 344.36 Million | 166.6 Million | 78.25 Million |
Net Income | 62.34 Million | 271.84 Million | 258.69 Million | 171.42 Million | 101.45 Million | 71.94 Million |
Depreciation & Amortization | 130.7 Million | 119.72 Million | 85.93 Million | 51.85 Million | 44.29 Million | 39.08 Million |
Deferred income taxes | -21.47 Million | 36.47 Million | -7.57 Million | -8.82 Million | -2.95 Million | -3.74 Million |
Stock-based compensation | 13.76 Million | 16.76 Million | 17.77 Million | 10.43 Million | - | - |
Change in working capital | -221.06 Million | -441.67 Million | -161.18 Million | 23.01 Million | -19.69 Million | -77.92 Million |
Other non-cash items | 55.1 Million | -126.56 Million | 90.32 Million | 96.46 Million | 40.54 Million | 45.15 Million |
Investing Cash Flow | -572.95 Million | -603.61 Million | -274.76 Million | -158 Million | -126.13 Million | -331.82 Million |
Investments in PPE | -601.83 Million | -537.32 Million | -359.44 Million | -139.59 Million | -115.83 Million | -51.63 Million |
Acquisitions | -32 Million | -76.77 Million | -88.18 Million | -79.04 Million | -19.52 Million | -118.71 Million |
Investment purchases | -5.1 Million | -31.95 Million | -31.03 Million | -19.85 Million | -44 Million | -32.88 Million |
Sales/Maturities of investments | 60.24 Million | 39.24 Million | 36.3 Million | 24.22 Million | 38.2 Million | 20.7 Million |
Other Investing Activities | 3.95 Million | 3.18 Million | 167.59 Million | 56.25 Million | 15.02 Million | -149.29 Million |
Financing Cash Flow | 111.18 Million | 1.01 Billion | -78.75 Million | -332.09 Million | 539.24 Million | 346.9 Million |
Debt repayment | -256.64 Million | -1.16 Billion | -561.04 Million | -584.24 Million | -426.5 Million | -13.4 Million |
Dividends payments | -62.95 Million | -78.01 Million | -57.87 Million | -30.17 Million | -23.8 Million | -39.64 Million |
Common Stock Repurchased | -13.28 Million | -998.6 Thousand | -173 Thousand | -59.98 Million | -49.38 Million | -10.62 Million |
Common Stock Issuance | - | 998.59 Thousand | 173 Thousand | 59.98 Million | 49.38 Million | -3.63 Million |
Other Financing Activities | -43.31 Million | 2.28 Billion | 545.41 Million | 295.63 Million | 1.01 Billion | 373.15 Million |
Accounts receivables | -188.17 Million | -90.3 Million | -92.5 Million | -134.67 Million | -214.15 Million | -166.36 Million |
Accounts payables | 647.96 Million | 75.42 Million | 288.52 Million | 369.24 Million | 236.9 Million | 250.65 Million |
Inventory | -659.37 Million | -463.26 Million | -349.63 Million | -202.73 Million | -39.48 Million | -158.47 Million |
Other working capital | 12.43 Million | 36.47 Million | -7.57 Million | -8.82 Million | -2.95 Million | 80.55 Million |
Cash at beginning of period | 974.86 Million | 682.9 Million | 755.89 Million | 904.99 Million | 325 Million | 231.46 Million |
Cash at end of period | 728.55 Million | 974.86 Million | 682.9 Million | 755.89 Million | 904.99 Million | 325 Million |
Capital Expenditure | -601.83 Million | -537.32 Million | -359.44 Million | -139.59 Million | -115.83 Million | -51.63 Million |
Effect of forex changes on cash | 415.07 Thousand | 6.28 Million | -3.41 Million | -3.37 Million | 274.27 Thousand | 197.85 Thousand |
Net cash flow / Change in cash | -246.31 Million | 291.95 Million | -72.98 Million | -149.1 Million | 579.99 Million | 93.53 Million |
Free Cash Flow | -386.78 Million | -660.76 Million | -75.49 Million | 204.77 Million | 50.76 Million | 26.62 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 10.27 Million | 29.89 Million | 38.46 Million | -95.4 Million | 62.34 Million | 32.77 Million |
Depreciation & Amortization | - | 39.18 Million | 39.18 Million | 33.35 Million | 130.7 Million | -64.33 Million |
Deferred income taxes | - | - | - | - | -21.47 Million | -376.77 Million |
Stock-based compensation | - | - | - | 13.76 Million | 13.76 Million | -5.73 Million |
Change in working capital | - | - | - | -835.11 Million | -221.06 Million | 442.33 Million |
Other non-cash items | 40.16 Million | 138.64 Million | -238.31 Million | 382.07 Million | 55.1 Million | -20.91 Million |
Investing Cash Flow | -53.95 Million | -54.26 Million | -158.96 Million | -143.91 Million | -572.95 Million | -100.15 Million |
Investments in PPE | -67.7 Million | -98.75 Million | -125.56 Million | -185.41 Million | -601.83 Million | -104.75 Million |
Acquisitions | 13.74 Million | 8.93 Million | 28.7 Thousand | -40.45 Million | -32 Million | 83.19 Thousand |
Investment purchases | - | 20.5 Million | -26.22 Million | -3.6 Million | -5.1 Million | -83.19 Thousand |
Sales/Maturities of investments | - | 13.85 Million | 2.91 Million | 43.52 Million | 60.24 Million | 4.51 Million |
Other Investing Activities | - | 9.02 Million | -10.12 Million | 41.49 Million | 3.95 Million | 83.19 Thousand |
Financing Cash Flow | 36.43 Million | -55.74 Million | 89.61 Million | -80.93 Million | 111.18 Million | -16.58 Million |
Debt repayment | -76.05 Million | -4.51 Million | -120.14 Million | -5.4 Million | -256.64 Million | -103.45 Million |
Dividends payments | - | -30.78 Million | -9.63 Million | -4.46 Million | -62.95 Million | -16.57 Million |
Common Stock Repurchased | 17.62 Million | -17.62 Million | - | -13.28 Million | -13.28 Million | 27.78 Million |
Common Stock Issuance | - | - | - | - | - | -27.78 Million |
Other Financing Activities | -57.24 Million | -20.45 Million | -20.88 Million | -70.06 Million | -43.31 Million | 103.44 Million |
Accounts receivables | - | - | - | -188.17 Million | -188.17 Million | 209.83 Million |
Accounts payables | - | - | - | - | 647.96 Million | 5.75 Million |
Inventory | - | - | - | -659.37 Million | -659.37 Million | 232.5 Million |
Other working capital | - | - | - | 12.43 Million | 12.43 Million | -5.75 Million |
Cash at beginning of period | 485.5 Million | 457.85 Million | 728.55 Million | 691.76 Million | 974.86 Million | 800.98 Million |
Cash at end of period | 515.43 Million | 472.05 Million | 457.85 Million | 728.55 Million | 728.55 Million | 691.76 Million |
Capital Expenditure | -67.7 Million | -98.75 Million | -125.56 Million | -185.41 Million | -601.83 Million | -104.75 Million |
Effect of forex changes on cash | - | 2.7 Million | 661.73 Thousand | -1.55 Million | 415.07 Thousand | 175.47 Thousand |
Net cash flow / Change in cash | 29.93 Million | 14.19 Million | -270.69 Million | 36.78 Million | -246.31 Million | -109.21 Million |
Free Cash Flow | -17.26 Million | 30.59 Million | -325.41 Million | 67.89 Million | -386.78 Million | -97.4 Million |
DOSE
2065
9850
1472
1416
APTECHT